Published in Proc Natl Acad Sci U S A on September 12, 2011
PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol (2014) 3.02
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
Fibroblast heterogeneity in the cancer wound. J Exp Med (2014) 2.09
Metastatic stem cells: sources, niches, and vital pathways. Cell Stem Cell (2014) 1.88
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol (2013) 1.73
Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol (2014) 1.71
S100 proteins in cancer. Nat Rev Cancer (2015) 1.35
What does the concept of the stem cell niche really mean today? BMC Biol (2012) 1.32
The metastatic niche and stromal progression. Cancer Metastasis Rev (2012) 1.30
Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. Cancer Res (2012) 1.19
Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br J Cancer (2013) 1.17
The biology and function of fibroblasts in cancer. Nat Rev Cancer (2016) 1.16
Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol (2015) 1.15
Extracellular matrix players in metastatic niches. EMBO J (2011) 1.13
Insidious changes in stromal matrix fuel cancer progression. Mol Cancer Res (2014) 1.09
Cell surface remodeling by plasmin: a new function for an old enzyme. J Biomed Biotechnol (2012) 1.04
Carcinoma-associated fibroblasts are a promising therapeutic target. Cancers (Basel) (2013) 1.01
Active roles of tumor stroma in breast cancer metastasis. Int J Breast Cancer (2012) 0.98
Cancer-associated fibroblasts promote proliferation of endometrial cancer cells. PLoS One (2013) 0.97
Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody. PLoS One (2013) 0.95
Emerging roles of the tumor-associated stroma in promoting tumor metastasis. Cell Adh Migr (2012) 0.94
miR-29b moulds the tumour microenvironment to repress metastasis. Nat Cell Biol (2013) 0.94
Targeting ECM Disrupts Cancer Progression. Front Oncol (2015) 0.92
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Surviving at a distance: organ specific metastasis. Trends Cancer (2015) 0.90
Fibulin-2 is a driver of malignant progression in lung adenocarcinoma. PLoS One (2013) 0.89
Metastatic mechanisms in follicular cell-derived thyroid cancer. Endocr Relat Cancer (2013) 0.88
Fibroblasts--a key host cell type in tumor initiation, progression, and metastasis. Ups J Med Sci (2012) 0.88
Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling. Oncogene (2015) 0.88
Stromal biomarkers in breast cancer development and progression. Clin Exp Metastasis (2012) 0.86
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. Neoplasia (2012) 0.86
Tenascin-C: Exploitation and collateral damage in cancer management. Cell Adh Migr (2015) 0.85
Tenascin C promiscuously binds growth factors via its fifth fibronectin type III-like domain. PLoS One (2013) 0.84
Network fingerprint: a knowledge-based characterization of biomedical networks. Sci Rep (2015) 0.83
Tenascin-C and integrins in cancer. Cell Adh Migr (2015) 0.82
S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis. Mol Vis (2014) 0.82
Bone marrow-derived mesenchymal stem cells drive lymphangiogenesis. PLoS One (2014) 0.82
Studying primary tumor-associated fibroblast involvement in cancer metastasis in mice. Nat Protoc (2012) 0.81
Tenascin C in metastasis: A view from the invasive front. Cell Adh Migr (2015) 0.81
Priming cancer cells for drug resistance: role of the fibroblast niche. Front Biol (Beijing) (2014) 0.80
Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series. Biosci Rep (2013) 0.80
SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients. Mol Cancer (2014) 0.80
S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction. Cancers (Basel) (2016) 0.79
Bone marrow cells as precursors of the tumor stroma. Exp Cell Res (2013) 0.79
S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance. BMC Cancer (2015) 0.79
From transformation to metastasis: deconstructing the extracellular matrix in breast cancer. Cancer Metastasis Rev (2016) 0.78
Development of individualized anti-metastasis strategies by engineering nanomedicines. Chem Soc Rev (2015) 0.77
Transcriptional regulation of tenascin-W by TGF-beta signaling in the bone metastatic niche of breast cancer cells. Int J Cancer (2015) 0.77
SHARPIN regulates collagen architecture and ductal outgrowth in the developing mouse mammary gland. EMBO J (2016) 0.76
Exosomes: The Link between GPCR Activation and Metastatic Potential? Front Genet (2016) 0.76
Fibroblasts, an inconspicuous but essential player in colon cancer development and progression. World J Gastroenterol (2016) 0.76
S100A4 protects the myocardium against ischemic stress. J Mol Cell Cardiol (2016) 0.76
MYC is expressed in the stromal and epithelial cells of primary breast carcinoma and paired nodal metastases. Mol Clin Oncol (2015) 0.75
Cellular organization and molecular differentiation model of breast cancer-associated fibroblasts. Mol Cancer (2017) 0.75
Tenascin-C Signaling in melanoma. Cell Adh Migr (2015) 0.75
Physiologically activated mammary fibroblasts promote postpartum mammary cancer. JCI Insight (2017) 0.75
Distinct prognostic values of S100 mRNA expression in breast cancer. Sci Rep (2017) 0.75
Spatial organization of the tenascin-C microenvironment in experimental and human cancer. Cell Adh Migr (2015) 0.75
The role of the cell-cell interactions in cancer progression. J Cell Mol Med (2015) 0.75
Lung carcinogenesis and fibrosis taken together: just coincidence? Curr Opin Pulm Med (2017) 0.75
Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proc Natl Acad Sci U S A (2017) 0.75
S100A4 is a biomarker and regulator of glioma stem cells that is critical for mesenchymal transition in glioblastoma. Cancer Res (2017) 0.75
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer (2003) 22.78
A molecular signature of metastasis in primary solid tumors. Nat Genet (2002) 21.36
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
A perspective on cancer cell metastasis. Science (2011) 13.31
The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 13.15
Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol (2003) 8.95
Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem (1998) 8.30
Identification and characterization of a fibroblast marker: FSP1. J Cell Biol (1995) 6.33
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell (2003) 3.68
The war on cancer. Lancet (1996) 3.38
The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res (2003) 2.67
Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res (2000) 2.29
Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Dev (1989) 2.07
Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther (2001) 1.95
Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene. Cancer Res (2005) 1.89
The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer (2005) 1.78
Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res (1997) 1.68
Cancer metastasis as a therapeutic target. Eur J Cancer (2010) 1.60
Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. Int J Cancer (2007) 1.53
Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Oncogene (1997) 1.43
Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res (1995) 1.40
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. Cancer Res (1996) 1.35
Nerve growth factor induces the genes for two proteins related to a family of calcium-binding proteins in PC12 cells. Proc Natl Acad Sci U S A (1988) 1.28
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer. Clin Breast Cancer (2003) 1.21
Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin Cancer Res (2004) 1.20
Effect of mts1 (S100A4) expression on the progression of human breast cancer cells. Int J Cancer (1996) 1.17
Molecular cloning and sequence of the gene for p9Ka. A cultured myoepithelial cell protein with strong homology to S-100, a calcium-binding protein. J Mol Biol (1987) 1.14
A growth-related mRNA in cultured mouse cells encodes a placental calcium binding protein. Nucleic Acids Res (1987) 1.08
Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors. Cancer Res (2010) 1.07
Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer. Br J Cancer (2000) 0.93
Isolation and characterization of a calcium-binding protein derived from mRNA termed p9Ka, pEL-98, 18A2, or 42A by the newly synthesized vasorelaxant W-66 affinity chromatography. Arch Biochem Biophys (1992) 0.92
Different expression and clinical role of S100A4 in serous ovarian carcinoma at different anatomic sites. Tumour Biol (2009) 0.86
Increased abundance of a normal cell mRNA sequence accompanies the conversion of rat mammary cuboidal epithelial cells to elongated myoepithelial-like cells in culture. Nucleic Acids Res (1984) 0.83
Fibroblasts in cancer. Nat Rev Cancer (2006) 18.95
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest (2002) 12.22
Stromal fibroblasts in cancer initiation and progression. Nature (2004) 11.69
The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol (2006) 11.16
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med (2007) 9.51
Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76
BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat Med (2003) 7.91
Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature (2012) 6.65
Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol (2008) 5.83
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function. Nat Genet (2005) 5.53
Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem (2007) 5.37
Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med (2010) 4.88
Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med (2003) 4.77
Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest (2004) 4.65
Origin and function of myofibroblasts in kidney fibrosis. Nat Med (2013) 4.55
Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther (2006) 4.20
Modification of kidney barrier function by the urokinase receptor. Nat Med (2007) 4.01
Cell growth and size homeostasis in proliferating animal cells. Science (2009) 3.89
Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res (2007) 3.86
Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med (2010) 3.78
Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol (2010) 3.75
Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell (2003) 3.68
eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell (2012) 3.63
Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat Med (2010) 3.60
Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem (2003) 3.36
The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl) (2004) 3.32
Handoffs in the era of duty hours reform: a focused review and strategy to address changes in the Accreditation Council for Graduate Medical Education Common Program Requirements. Acad Med (2012) 3.30
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell (2012) 3.19
Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int (2002) 3.16
Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci U S A (2006) 3.03
Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs (2009) 2.90
Endogenous inhibitors of angiogenesis. Cancer Res (2005) 2.88
Loss of β1-integrin from urothelium results in overactive bladder and incontinence in mice: a mechanosensory rather than structural phenotype. FASEB J (2013) 2.86
Mechanisms of metastasis: epithelial-to-mesenchymal transition and contribution of tumor microenvironment. J Cell Biochem (2007) 2.67
The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res (2003) 2.67
Cancer without disease. Nature (2004) 2.65
Physiology of the prion protein. Physiol Rev (2008) 2.65
Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int (2005) 2.58
Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med (2013) 2.55
Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med (2009) 2.53
An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide). Cancer Discov (2013) 2.52
Biomolecular characterization and protein sequences of the Campanian hadrosaur B. canadensis. Science (2009) 2.48
Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med (2012) 2.44
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene (2005) 2.35
Antibodies against macrophages that overlap in specificity with fibroblasts. Kidney Int (2005) 2.34
Structure and function of basement membranes. Exp Biol Med (Maywood) (2007) 2.29
Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci U S A (2003) 2.28
Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science (2002) 2.28
TGF-β1-containing exosomes from injured epithelial cells activate fibroblasts to initiate tissue regenerative responses and fibrosis. J Am Soc Nephrol (2012) 2.24
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A (2011) 2.21
Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol (2003) 2.20
The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol (2010) 2.18
Exploiting cancer cell vulnerabilities to develop a combination therapy for ras-driven tumors. Cancer Cell (2011) 2.17
Renal fibroblasts and myofibroblasts in chronic kidney disease. J Am Soc Nephrol (2006) 2.17
Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem (2004) 2.13
Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med (Berl) (2013) 2.12
Characterization of fibroblast-specific protein 1 in pulmonary fibrosis. Am J Respir Crit Care Med (2004) 2.10
Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature (2008) 2.09
Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res (2006) 2.07
The role of the microenvironment in mammary gland development and cancer. Cold Spring Harb Perspect Biol (2010) 2.03
BMP-7 functions as a novel hormone to facilitate liver regeneration. FASEB J (2006) 2.02
Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology (2003) 1.97
Phenotype of microsatellite unstable colorectal carcinomas: Well-differentiated and focally mucinous tumors and the absence of dirty necrosis correlate with microsatellite instability. Am J Surg Pathol (2003) 1.97
Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes (2007) 1.94
Determinants of vascular permeability in the kidney glomerulus. J Biol Chem (2002) 1.93
A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest (2007) 1.93